This line of investigation also demonstrated that the KRAS protein levels in tumors that originated in the EF1-tTA-based transgenic model (i.e., tumor samples a–c) were similar to those tumors that express mutant KRAS from the endogenous locus. Here, KRAS is linked to neoplasm.